U.S. markets open in 5 hours 40 minutes
  • S&P Futures

    3,686.00
    +31.75 (+0.87%)
     
  • Dow Futures

    29,481.00
    +196.00 (+0.67%)
     
  • Nasdaq Futures

    11,338.50
    +110.25 (+0.98%)
     
  • Russell 2000 Futures

    1,700.10
    +18.00 (+1.07%)
     
  • Crude Oil

    82.00
    +0.77 (+0.95%)
     
  • Gold

    1,679.40
    +10.80 (+0.65%)
     
  • Silver

    19.10
    +0.39 (+2.10%)
     
  • EUR/USD

    0.9824
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    3.7470
    0.0000 (0.00%)
     
  • Vix

    31.25
    +1.07 (+3.55%)
     
  • GBP/USD

    1.1148
    +0.0025 (+0.22%)
     
  • USD/JPY

    144.4160
    -0.0270 (-0.02%)
     
  • BTC-USD

    19,597.40
    +272.65 (+1.41%)
     
  • CMC Crypto 200

    447.82
    +1.84 (+0.41%)
     
  • FTSE 100

    6,933.14
    +51.55 (+0.75%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

Quantum-Si to Participate at Two Upcoming Investor Conferences

·1 min read

GUILFORD, Conn., July 29, 2022--(BUSINESS WIRE)--Jul. 29, 2022 --Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a life sciences company commercializing the first next generation single molecule protein sequencing platform, today announced that it will be participating in two upcoming investor conferences. Patrick Schneider, Quantum-Si’s President and Chief Operating Officer, will participate in fireside chats at both events. The discussions will cover recent company developments, including progress toward commercialization of Quantum-Si’s groundbreaking PlatinumTM instrument, which will be the first system to enable next-generation, single-molecule protein sequencing.

  • Canaccord Genuity 42nd Annual Growth Conference
    Patrick Schneider, President and Chief Operating Officer, will participate in a fireside chat on Wednesday, August 10, 2022 at 8:30 am ET.

  • UBS Genomics 2.0 and MedTech Innovations Summit
    Patrick Schneider, President and Chief Operating Officer, will participate in a fireside chat on Thursday, August 11, 2022 at 3:00 pm PT.

Live and archived webcasts of the events will be available in the Investors section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220729005108/en/

Contacts

Investor
Juan Avendano
ir@quantum-si.com

Media
Karen Chase
QSI-PR@westwicke.com